Erythroblastosis fetalis is a condition manifested by anemia that develops in an unborn infant when maternal antibodies, usually caused by Rh incompatibility between the mother's blood type and that of the fetus, attack the red blood cells of the fetus. An intrauterine transfusion of blood may be indicated.
Review Date 12/13/2017
Updated by: Kimberly G. Lee, MD, MSc, IBCLC, Associate Professor of Pediatrics, Division of Neonatology, Medical University of South Carolina, Charleston, SC. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.